<DOC>
	<DOCNO>NCT02014454</DOCNO>
	<brief_summary>The aim present study evaluate safety efficacy propranolol eye drop preterm newborn precocious stage retinopathy prematurity ( ROP ) . Preterm newborn ( gestational age 23-32 week ) stage 2 ROP ( zone II without plus ) receive propranolol eye drop treatment retinal vascularization complete . Propranolol concentration measure dried blood spot first 3 day treatment steady state . Cardiovascular respiratory parameter continuously monitor . Blood sampling check metabolic , renal liver function perform periodically , well cardiac function , order verify treatment safety . Serial ophthalmological evaluation plan monitor efficacy treatment , ROP progression possible complication .</brief_summary>
	<brief_title>Safety Efficacy Propranolol Eye Drops Treating Retinopathy Premature</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Retinopathy Prematurity</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Preterm newborn ( gestational age 2332 week ) stage 2 ROP , zone II without plus . A signed parental inform consent . Newborns heart failure ; Newborns congenital cardiovascular anomaly , except persistent ductus arteriosus , patent foramen ovale small ventricular septal defect ; Newborns recurrent bradycardia ( heart rate &lt; 90 beat per minute ) ; Newborns second third degree atrioventricular block ; Newborns hypotension ; Newborns renal failure ; Newborns actual cerebral haemorrhage ; Newborns diseases contraindicate use betaadrenoreceptor blocker .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>4 Months</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Retinopathy prematurity</keyword>
	<keyword>Propranolol</keyword>
	<keyword>Eye drop</keyword>
	<keyword>Newborns</keyword>
	<keyword>Retinal angiogenesis</keyword>
	<keyword>Retinal neovascularization</keyword>
</DOC>